<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2023-9-4-0-7</article-id><article-id pub-id-type="publisher-id">3249</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacology</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Curcumin Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Endoplasmic Reticulum Stress in The Liver&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Curcumin Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Endoplasmic Reticulum Stress in The Liver&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Rahmadi</surname><given-names>Mahardian</given-names></name><name xml:lang="en"><surname>Rahmadi</surname><given-names>Mahardian</given-names></name></name-alternatives><email>mahardianr@ff.unair.ac.id</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Nurhan</surname><given-names>Ahmad D.</given-names></name><name xml:lang="en"><surname>Nurhan</surname><given-names>Ahmad D.</given-names></name></name-alternatives><email>ahmad.dzulfikri.nurhan-2019@ff.unair.ac.id</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Ananda</surname><given-names>Maulidany R.D.</given-names></name><name xml:lang="en"><surname>Ananda</surname><given-names>Maulidany R.D.</given-names></name></name-alternatives><email>maulidany.rifkha.dwi.ananda-2017@ff.unair.ac.id</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Ramadhani</surname><given-names>Annisa D.S.</given-names></name><name xml:lang="en"><surname>Ramadhani</surname><given-names>Annisa D.S.</given-names></name></name-alternatives><email>annisa.dayu.syifa.ramadhani-2017@ff.unair.ac.id</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Iqbal</surname><given-names>Zuhaela</given-names></name><name xml:lang="en"><surname>Iqbal</surname><given-names>Zuhaela</given-names></name></name-alternatives><email>zuhaela.iqbal-2021@ff.unair.ac.id</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Balan</surname><given-names>Santhra S.</given-names></name><name xml:lang="en"><surname>Balan</surname><given-names>Santhra S.</given-names></name></name-alternatives><email>santhra@msu.edu.my</email></contrib></contrib-group><pub-date pub-type="epub"><year>2023</year></pub-date><volume>9</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2023/4/НР_Медицина-96-107.pdf" /><abstract xml:lang="ru"><p>Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic pathological condition of the liver due to excess triglyceride accumulation in hepatocytes. The antioxidant properties of curcumin improve lipid dysregulation and reduce reactive oxygen species (ROS). The aim of the study: This study explores the effects of curcumin administration on beclin-1 and microtubule-associated protein light chain-3 (LC3) expression as autophagy markers and XBP1 spliced as a marker indicating endoplasmic reticulum stress in ameliorating HFD-induced NAFLD in mice. Materials and methods: Twenty-four ddY male mice were divided into four groups: the normal chow group, high-fat diet (HFD) group, HFD with curcumin 50 mg/kg for 28 days group, and HFD with curcumin 100 mg/kg for 28 days group. Bodyweight and food intake were measured daily, and curcumin was administered intraperitoneally. The animals were sacrificed 24 hours after the last treatment. The liver was collected for macroscopic and histopathological assessment and molecular analysis using the reverse transcription-polymerase chain reaction (PCR) method. Results: Curcumin 50 and 100 mg/kg improved macroscopic and histopathological features of the liver. The results of the molecular analysis showed that curcumin 50 and 100 mg/kg did not increase the beclin-1 or LC3 mRNA expression in the liver (p&amp;gt;0.05). Meanwhile, curcumin 100 mg/kg significantly increases the XBP1 spliced expression in the liver (p&amp;lt;0.05), which indicates that curcumin modulates endoplasmic stress induced-NAFLD in a dose-dependent manner. Conclusion: Curcumin overcomes endoplasmic reticulum stress in the high-fat diet-induced NAFLD in mice.</p></abstract><trans-abstract xml:lang="en"><p>Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic pathological condition of the liver due to excess triglyceride accumulation in hepatocytes. The antioxidant properties of curcumin improve lipid dysregulation and reduce reactive oxygen species (ROS). The aim of the study: This study explores the effects of curcumin administration on beclin-1 and microtubule-associated protein light chain-3 (LC3) expression as autophagy markers and XBP1 spliced as a marker indicating endoplasmic reticulum stress in ameliorating HFD-induced NAFLD in mice. Materials and methods: Twenty-four ddY male mice were divided into four groups: the normal chow group, high-fat diet (HFD) group, HFD with curcumin 50 mg/kg for 28 days group, and HFD with curcumin 100 mg/kg for 28 days group. Bodyweight and food intake were measured daily, and curcumin was administered intraperitoneally. The animals were sacrificed 24 hours after the last treatment. The liver was collected for macroscopic and histopathological assessment and molecular analysis using the reverse transcription-polymerase chain reaction (PCR) method. Results: Curcumin 50 and 100 mg/kg improved macroscopic and histopathological features of the liver. The results of the molecular analysis showed that curcumin 50 and 100 mg/kg did not increase the beclin-1 or LC3 mRNA expression in the liver (p&amp;gt;0.05). Meanwhile, curcumin 100 mg/kg significantly increases the XBP1 spliced expression in the liver (p&amp;lt;0.05), which indicates that curcumin modulates endoplasmic stress induced-NAFLD in a dose-dependent manner. Conclusion: Curcumin overcomes endoplasmic reticulum stress in the high-fat diet-induced NAFLD in mice.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>nonalcoholic fatty liver disease</kwd><kwd>curcumin</kwd><kwd>endoplasmic reticulum stress</kwd><kwd>high-fat diet</kwd><kwd>beclin-1</kwd><kwd>light chain-3</kwd><kwd>XBP1</kwd></kwd-group><kwd-group xml:lang="en"><kwd>nonalcoholic fatty liver disease</kwd><kwd>curcumin</kwd><kwd>endoplasmic reticulum stress</kwd><kwd>high-fat diet</kwd><kwd>beclin-1</kwd><kwd>light chain-3</kwd><kwd>XBP1</kwd></kwd-group></article-meta></front><back><ack><p>The authors thanks the Department of Pharmacy Practice, Faculty of Pharmacy, Airlangga University and Biomedical Pharmacy Research Group, Faculty of Pharmacy, Airlangga University for all support during research</p></ack><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Zhang L, Yao Z, Ji G. Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy. Frontiers in Pharmacology. 2018;9:1459. DOI: https://doi.org/10.3389/fphar.2018.01459</mixed-citation></ref><ref id="B2"><mixed-citation>Anstee QM, McPherson S, Day CP. How big a problem is non-alcoholic fatty liver disease? BMJ. 2011;343(7816):d3897. DOI: https://doi.org/10.1136/bmj.d3897</mixed-citation></ref><ref id="B3"><mixed-citation>Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease&amp;ndash;meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. DOI: https://doi.org/10.1002/hep.28431</mixed-citation></ref><ref id="B4"><mixed-citation>Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology and Hepatology. 2018;15(1):11-20. DOI: https://doi.org/10.1038/nrgastro.2017.109</mixed-citation></ref><ref id="B5"><mixed-citation>Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases, Translational Gastroenterology and Hepatology. 2020;5:16. DOI: https://doi.org/10.21037/TGH.2019.09.08</mixed-citation></ref><ref id="B6"><mixed-citation>Yu J, Marsh S, Hu J, et al. The pathogenesis of nonalcoholic fatty liver disease: interplay between diet, gut microbiota, and genetic background. Gastroenterology Resesearch and Practice. 2016;2016:2862173. DOI: https://doi.org/10.1155/2016/2862173</mixed-citation></ref><ref id="B7"><mixed-citation>Marzio HD, Dina L, Fenkel, JM. Concepts and treatment approaches in nonalcoholic fatty liver disease.&amp;nbsp;Advance in Hepatology.&amp;nbsp;2014;2014:357965. DOI: https://doi.org/10.1155/2014/357965</mixed-citation></ref><ref id="B8"><mixed-citation>Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836-1846. DOI: https://doi.org/10.1002/hep.24001</mixed-citation></ref><ref id="B9"><mixed-citation>Maiuri MC, De Stefano D. Autophagy Networks in Inflammation. Springer International Publishing; 2016. DOI: https://doi.org/10.1007/978-3-319-30079-5</mixed-citation></ref><ref id="B10"><mixed-citation>Lavallard VJ, Gual P. Autophagy and non-alcoholic fatty liver disease. BioMed Research International. 2014;2014:120179. DOI: https://doi.org/10.1155/2014/120179</mixed-citation></ref><ref id="B11"><mixed-citation>Mao Y, Yu F, Wang J, et al. Autophagy: a new target for nonalcoholic fatty liver disease therapy. Hepatic Medicine: Evidence and Research. 2016;8:27-37. DOI: https://doi.org/10.2147/HMER.S98120</mixed-citation></ref><ref id="B12"><mixed-citation>Meng YC, Lou XL, Yang LY, et al. Role of the autophagy-related marker LC3 expression in hepatocellular carcinoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology. 2020;146(5):1103-1113. DOI: https://doi.org/10.1007/s00432-020-03174-1</mixed-citation></ref><ref id="B13"><mixed-citation>Bortolami M, Comparato A, Benna C, et al. Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and &amp;ldquo;normal&amp;rdquo; liver tissues. PLoS ONE. 2020;15(12):e0244356. DOI: https://doi.org/10.1371/journal.pone.0244356</mixed-citation></ref><ref id="B14"><mixed-citation>Lebeaupin C, Vall&amp;eacute;e D, Hazari Y, et al. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. Journal of Hepatology. 2018;69(4):927-947. DOI: https://doi.org/10.1016/j.jhep.2018.06.008</mixed-citation></ref><ref id="B15"><mixed-citation>Pagliassotti MJ. Endoplasmic reticulum stress in nonalcoholic fatty liver disease. Annual Review of Nutrition. 2012;32:17-33. DOI: https://doi.org/10.1146/annurev-nutr-071811-150644</mixed-citation></ref><ref id="B16"><mixed-citation>Yoon SB, Park YH, Choi SA, et al. Real-time PCR quantification of spliced X-box binding protein 1 (XBP1) using a universal primer method. PLoS ONE. 2019;14(7):e0219978. DOI: https://doi.org/10.1371/journal.pone.0219978</mixed-citation></ref><ref id="B17"><mixed-citation>Mansour-Ghanaei F, Pourmasoumi M, Hadi A, et al. Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials. Integrative Medicine Research. 2019;8(1):57-61. DOI: https://doi.org/10.1016/j.imr.2018.07.004</mixed-citation></ref><ref id="B18"><mixed-citation>Nurhan AD, Gani MA, Budiatin AS, et al. Molecular docking studies of Nigella sativa L and Curcuma xanthorrhiza Roxb secondary metabolites against histamine N-methyltransferase with their ADMET prediction. Journal of Basic and Clinical Physiology and Pharmacology. 2021;32(4):795-802. DOI: https://doi.org/10.1515/jbcpp-2020-0425</mixed-citation></ref><ref id="B19"><mixed-citation>Gani MA, Nurhan AD, Maulana S, et al. Structure-based virtual screening of bioactive compounds from Indonesian medical plants against severe acute respiratory syndrome coronavirus-2. Journal of Advanced Pharmaceutical Technology and Research. 2021;12(2):120-126. DOI: https://doi.org/10.4103/japtr.JAPTR_88_21</mixed-citation></ref><ref id="B20"><mixed-citation>Sala de Oyanguren FJ, Rainey NE, Moustapha A, et al. Highlighting curcumin-induced crosstalk between autophagy and apoptosis as supported by its specific subcellular localization. Cells. 2020;9(2):361. DOI: https://doi.org/10.3390/cells9020361</mixed-citation></ref><ref id="B21"><mixed-citation>Deng S, Shanmugam MK, Kumar AP, et al. Targeting autophagy using natural compounds for cancer prevention and therapy. Cancer. 2019;125(8):1228-1246. DOI: https://doi.org/10.1002/cncr.31978</mixed-citation></ref><ref id="B22"><mixed-citation>Al-Maamari JNS, Rahmadi M, Panggono SM, et al. The effects of quercetin on the expression of SREBP-1c mRNA in high-fat diet-induced NAFLD in mice. Journal of Basic and Clinical Physiology and Pharmacology. 2021;32(4):637-644. DOI: https://doi.org/10.1515/jbcpp-2020-0423</mixed-citation></ref><ref id="B23"><mixed-citation>Dkhar P, Sharma R. Attenuation of age-related increase of protein carbonylation in the liver of mice by melatonin and curcumin. Molecular and Cellular Biochemistry. 2013;380:153-160. DOI: https://doi.org/10.1007/s11010-013-1668-9</mixed-citation></ref><ref id="B24"><mixed-citation>Zhao NJ, Liao MJ, Wu JJ, et al. Curcumin suppresses Notch-1 signaling: Improvements in fatty liver and insulin resistance in rats. Molecular Medicine Reports. 2018;17(1):819-826. DOI: https://doi.org/10.3892/mmr.2017.7980</mixed-citation></ref><ref id="B25"><mixed-citation>Park EJ, Jeon CH, Ko G, et al. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. Journal of Pharmacy and Pharmacology. 2000;52(4):437-440. DOI: https://doi.org/10.1211/0022357001774048</mixed-citation></ref><ref id="B26"><mixed-citation>Recena Aydos L, Aparecida do Amaral L, Serafim de Souza R, et al. Nonalcoholic fatty liver disease induced by high-fat diet in C57bl/6 models. Nutrients. 2019;11(12):3067. DOI: https://doi.org/10.3390/nu11123067</mixed-citation></ref><ref id="B27"><mixed-citation>Rahmadi M, Nurhan AD, Pratiwi ED, et al. The effect of various high-fat diet on liver histology in the development of NAFLD models in mice. Journal of Basic and Clinical Physiology and Pharmacology. 2021;32(4):547-553. DOI: https://doi.org/10.1515/jbcpp-2020-0426</mixed-citation></ref><ref id="B28"><mixed-citation>Kanuri G, Bergheim I. In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). International Journal of Molecular Sciences. 2013;14(6):11963-11980. DOI: https://doi.org/10.3390/ijms140611963</mixed-citation></ref><ref id="B29"><mixed-citation>Alharbi A, Al-Sowayan NS. The effect of ketogenic-diet on health. Food and Nutrition Sciences. 2020;11(4):301-313. DOI: https://doi.org/10.4236/fns.2020.114022</mixed-citation></ref><ref id="B30"><mixed-citation>Anekwe CV, Chandrasekaran P, Stanford, FC. Ketogenic diet-induced elevated cholesterol, elevated liver enzymes and potential non-alcoholic fatty liver disease. Cureus. 2020;12(1):e6605. DOI: https://doi.org/10.7759/cureus.6605</mixed-citation></ref><ref id="B31"><mixed-citation>Takahashi Y, Fukusato T. Animal models of liver diseases. In: Animal Models for the Study of Human Disease (Second Edition). Academic Press; 2017:313-339. DOI: https://doi.org/10.1016/B978-0-12-809468-6.00013-9</mixed-citation></ref><ref id="B32"><mixed-citation>Podrini C, Cambridge EL, Lelliott CJ, et al. High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice. Mammalian Genome. 2013;24(5-6):240-251. DOI: https://doi.org/10.1007/s00335-013-9456-0</mixed-citation></ref><ref id="B33"><mixed-citation>Mun J, Kim S, Yoon HG, et al. Water extract of Curcuma longa L. ameliorates non-alcoholic fatty liver disease. Nutrients. 2019;11(10):2536. DOI: https://doi.org/10.3390/nu11102536</mixed-citation></ref><ref id="B34"><mixed-citation>Naito H, Yoshikawa-Bando Y, Yuan Y, et al. High-fat and high-cholesterol diet decreases phosphorylated inositol-requiring kinase-1 and inhibits autophagy process in rat liver.&amp;nbsp;Scientific Reports. 2019;9(1):12514. DOI: https://doi.org/10.1038/s41598-019-48973-w</mixed-citation></ref><ref id="B35"><mixed-citation>Lee AH, Scapa EF, Cohen DE, et al. Regulation of hepatic lipogenesis by the transcription factor XBP1.&amp;nbsp;Science.&amp;nbsp;2008;320(5882):1492-1496. DOI: https://doi.org/10.1126/science.1158042</mixed-citation></ref><ref id="B36"><mixed-citation>Wu R, Zhang QH, Lu YJ, et al. Involvement of the IRE1&amp;alpha;-XBP1 pathway and XBP1s-dependent transcriptional reprogramming in metabolic diseases. DNA and Cell Biology. 2015;34(1):6-18. DOI: https://doi.org/10.1089/dna.2014.2552</mixed-citation></ref><ref id="B37"><mixed-citation>Li J, Chen Z, Gao LY, et al. A transgenic zebrafish model for monitoring xbp1 splicing and endoplasmic reticulum stress in vivo. Mechanisms of Development. 2015;137:33-44. DOI: https://doi.org/10.1016/j.mod.2015.04.001</mixed-citation></ref><ref id="B38"><mixed-citation>Duarte M, Vende P, Charpilienne A, et al. Rotavirus infection alters splicing of the stress-related transcription factor XBP1. Journal of Virology. 2019;93(5):e01739-18. DOI: https://doi.org/10.1128/JVI.01739-18</mixed-citation></ref><ref id="B39"><mixed-citation>Yoshida H, Oku M, Suzuki M, et al. pXBP1 (U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1 (S) in mammalian ER stress response. Journal of Cell Biology. 2006;172(4):565-575. DOI: https://doi.org/10.1083/jcb.200508145</mixed-citation></ref><ref id="B40"><mixed-citation>Mimura N, Fulciniti M, Gorgun G, et al. Blockade of XBP1 splicing by inhibition of IRE1&amp;alpha; is a promising therapeutic option in multiple myeloma. Blood. 2012;119(24):5772-5781. DOI: https://doi.org/10.1182/blood-2011-07-366633</mixed-citation></ref><ref id="B41"><mixed-citation>Tsuru A, Imai Y, Saito M, et al. Novel mechanism of enhancing IRE1&amp;alpha;-XBP1 signalling via the PERK-ATF4 pathway. Scientific Reports. 2016;6(1):24217. DOI: https://doi.org/10.1038/srep24217</mixed-citation></ref></ref-list></back></article>